Osborne Fined in NSA Insider Trading Query Over Einhorn Deal

GREENLIGHT CAPITALThe chapter of the FSA’s insider trading fines against Greenlight Capital‘s David Einhorn over his sale of Punch Taverns stock may be over – Einhorn agreed to pay the fine – but it seems the FSA has yet to lay the matter to rest. According to the Financial Times, “UK regulators are seeking to fine a former Bank of America Merrill Lynch broker about £350,000 for his role in hedge fund manager David Einhorn’s improper trading ahead of the 2009 equity raising by Punch Taverns.”

“Andrew Osborne, who resigned from the bank late last year, is considering whether to appeal against the fine to a tribunal,” writes the Financial Times. “People familiar with his views said Mr Osborne, who served as corporate broker for the UK pubs company, consulted lawyers throughout his June 2009 interactions with Mr Einhorn and does not believe he gave the hedge fund executive inside information.”

The Financial Times also writes that “the FSA is also seeking to fine a bank that failed to flag Greenlight’s share sales as potentially problematic.” It explains, “Under UK law, institutions are supposed to file a ‘suspicious transaction report’ if they are involved in a transaction that appears to be unusually lucky in its timing.” The Financial Times reports that “that investigation is said to be close to a settlement.”

The FSA said that Einhorn learned on June 9, 2009, from a broker working for Punch, that the company was near an equity fundraising (read about it here). In response, Greenlight went from owning a 13.3% stake in Punch to a stake worth 8.9% of the company, and, in doing so, avoided £5.8 million in losses after Punch announced its fundraising on June 15. Einhorn defended his actions saying that he did not believe he was violating market abuse rules and that he still believes he did nothing wrong (read his side of the story here). The FSA said that the Punch tip “was inside information and Einhorn should have appreciated this,” and ordered Einhorn to pay £7.2 million (US$11.2 million), including a £3.7 million fine. Einhorn said when the fine was announced,“We believe this action is unjust and inconsistent with the law and with prior FSA enforcement precedent. However, rather than continue an arduous fight, we have decided to put this matter behind us.”

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!